Translational Dev Acquisition Stock Price, News & Analysis
TDACU
NASDAQ
Company Description
Welcome to the overview page for Translational Dev Acquisition (TDACU), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Translational Dev Acquisition.
Financial Highlights
-$71,012
Net Income (TTM)
-$851,446
Operating Cash Flow
3.09
-$196,358
—
Revenue (TTM)
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Translational Dev Acquisition (TDACU)?
The current stock price of Translational Dev Acquisition (TDACU) is $10.44 as of October 6, 2025.
What is the net income of Translational Dev Acquisition (TDACU)?
The trailing twelve months (TTM) net income of Translational Dev Acquisition (TDACU) is -$71,012.
What is the operating cash flow of Translational Dev Acquisition (TDACU)?
The operating cash flow of Translational Dev Acquisition (TDACU) is -$851,446. Learn about cash flow.
What is the current ratio of Translational Dev Acquisition (TDACU)?
The current ratio of Translational Dev Acquisition (TDACU) is 3.09, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Translational Dev Acquisition (TDACU)?
The operating income of Translational Dev Acquisition (TDACU) is -$196,358. Learn about operating income.